Current market catalysts

Why Is Marvell Stock Surging on Tuesday?

Marvell Technology Inc. (NASDAQ:MRVL) stock trades higher Tuesday following strong Q2 financial results and updated Q3 guidance.

GE Aerospace Makes $11.75 Billion Supply Chain Bet With CPP Acquisition

GE Aerospace to buy Consolidated Precision Products for $11.75B to boost casting capacity and meet commercial and defense demand.

XRAY's Q2 Earnings Beat Meets Steady Guidance and Margin Pressure

DENTSPLY SIRONA (XRAY) exceeded Q2 earnings and revenue estimates with adjusted EPS of 52 cents versus 36 cents consensus, though revenues fell 4.1% year-over-year. The company maintained full-year 2026 guidance of $3.5-3.6B in sales and $1.40-1.50 adjusted EPS. Wellspect Healthcare grew 7.1%, but three dental segments declined, with tariff pressures and lower volumes constraining operating margins. Free cash flow improved to $55M from $16M year-ago.

Billionaire Stanley Druckenmiller Has 2 Megacap Stocks Worth Watching (Hint: His Top Holding Isn't Amazon, Alphabet, or Nvidia)

Billionaire investor Stanley Druckenmiller holds positions in Amazon and Alphabet for AI infrastructure exposure, but his largest U.S. stock holding is Natera, a genetic diagnostics company that has returned approximately 10x since his initial investment in Q3 2022. Druckenmiller sold his Nvidia position in early 2024 due to valuation concerns and now holds Taiwan Semiconductor Manufacturing as his AI semiconductor bet instead.

Can Western Digital's Strong FCF Sustain Buybacks and Dividends?

Western Digital ended fiscal 2026 with $3.51 billion in free cash flow and a net cash position of $500 million, returning $3.1 billion to shareholders through dividends and buybacks. The company expects Q1 fiscal 2027 revenue of $4.1 billion with non-GAAP EPS of $4.00. Competitors Seagate and SanDisk also demonstrated strong profitability and cash generation, with expanding margins and continued shareholder return programs.

Earnings Estimates Rising for Marqeta (MQ): Will It Gain?

Marqeta (MQ) has received positive analyst attention with earnings estimates showing significant improvement. The company is expected to earn $0.07 per share for the current quarter (up 275% year-over-year) and $0.28 for the full year (up 333.3% year-over-year). Strong estimate revisions have earned the stock a Zacks Rank #2 (Buy) rating, with the stock gaining 6.3% over the past four weeks.

Portnoy Law Firm Announces Class Action on Behalf of Celsius Holdings, Inc. Investors

A class action lawsuit has been filed against Celsius Holdings (NASDAQ: CELH) on behalf of investors who purchased securities between February 21, 2025 and June 3, 2026. The complaint alleges that Celsius failed to disclose that its acquired Alani Nutrition drinks contain excessive caffeine (200mg per 12oz serving) and pose cardiac risks, particularly to minors under 18 whom the company allegedly targeted despite safety concerns. Investors have until November 3, 2026 to file a lead plaintiff motion.

DICK’S SPORTING GOODS, INC. (DKS) INVESTOR ALERT Investors With Large Losses in DICK’S Sporting Goods, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

A securities class action lawsuit has been filed against DICK'S Sporting Goods, Inc. on behalf of investors who purchased stock between September 8, 2025 and August 24, 2026. The lawsuit alleges the company made materially false and misleading statements regarding business operations, growth prospects, and financial stability, causing the stock to trade at artificially inflated prices. Investors who suffered losses are encouraged to contact the law firm or submit a form by November 3, 2026 if they wish to serve as lead plaintiff.

BETA BIONICS, INC. (BBNX) INVESTOR ALERT Investors With Large Losses in Beta Bionics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Bernstein Liebhard LLP has announced multiple shareholder class action lawsuits against Beta Bionics, Dick's Sporting Goods, and EquipmentShare.com for allegedly making materially false and misleading statements regarding their business operations and financial stability. Investors who purchased shares during specified periods are encouraged to contact the firm to discuss their rights and potential recovery.

Morgan Stanley Downgrades Zions Bancorp to Underweight, Maintains Price Target to $77

Morgan Stanley Maintains Equal-Weight on Valley National Bancorp, Raises Price Target to $17

Tesla and XPENG Are Taking Humanoid Robots to the Factory: 3 ETFs to Watch as Production Scales

Tesla and XPENG are pushing humanoid robots toward mass production. See how BOTT, KOID and HUMN ETFs are positioned for the next robotics boom.

Morgan Stanley Maintains Overweight on UMB Financial, Raises Price Target to $190

Morgan Stanley Downgrades Simmons First Ntl to Underweight, Raises Price Target to $26

Morgan Stanley Maintains Equal-Weight on Regions Financial, Raises Price Target to $36

Reddit CEO Says We See A Few Hundred Thousand Unattributed New App Downloads Daily; Says 1B New Posts, Comments Created In Last Quarter, About 4% Of Corpus

Morgan Stanley Downgrades Prosperity Bancshares to Underweight, Maintains Price Target to $80

8-K filing — DarkPulse, Inc. (DPLS)

Filed: 2026-09-08 AccNo: 0001683168-26-006998 Size: 182 KB Item 7.01: Regulation FD Disclosure

Morgan Stanley Initiates Coverage On Pinnacle Finl Partners with Overweight Rating, Announces Price Target of $137

Eric Trump Posts On X "Another great win for American Technology. These guys are amazing of what they do… @XTEND_XR" In Response To The Company Ringing The Opening Bell At The NYSE

Morgan Stanley Maintains Overweight on Onto Innovation, Lowers Price Target to $360

Morgan Stanley Maintains Equal-Weight on Merchants Bancorp, Raises Price Target to $65

Morgan Stanley Maintains Overweight on Ionis Pharmaceuticals, Lowers Price Target to $104

Morgan Stanley Initiates Coverage On First Horizon with Equal-Weight Rating, Announces Price Target of $30

Morgan Stanley Upgrades Flagstar Bank to Overweight, Raises Price Target to $17

Morgan Stanley Upgrades East West Bancorp to Overweight, Raises Price Target to $160

Morgan Stanley Downgrades Customers Bancorp to Underweight, Raises Price Target to $89

ABM Isn’t Just Cleaning Buildings Anymore — Its Data Center Pipeline Is Multiplying

ABM stock jumps 7% after beating Q3 2026 earnings estimates, boosted by semiconductor and data center growth. Read the snapshot.

Morgan Stanley Upgrades Cullen/Frost Bankers to Overweight, Raises Price Target to $200

Morgan Stanley Upgrades Commerce Bancshares to Overweight, Raises Price Target to $76